Table 2B.
T cells | B7 ICR | AML | Healthy controls |
---|---|---|---|
CD4+ | ICOS | 56.9% | 57.5% |
CTLA-4 | 3.6% | 1% | |
PD-1 | 19.1% | 15.8 | |
CD8+ | ICOS | 23.8% | 21.1% |
CTLA-4 | 1.5% | 0.2% | |
PD-1 | 27.7% | 27.2% |
AML, acute myeloid leukemia; BM, bone marrow; CTLA-4, cytotoxic T lymphocyte-associated protein 4; ICR, immune checkpoint receptor; PD-1, programmed death 1.